Guardant Health, Inc. (NASDAQ:GH) Q4 2025 Earnings Call Transcript February 19, 2026 Guardant Health, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.42.

Q4 2025 Management View Helmy Eltoukhy, Co-Founder, Co-CEO & Chairman, opened by stating, “2025 was a breakout year for Guardant, where years of investment continues to fuel breakthrough innovation ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ...

Guardant Health (NASDAQ:GH) reported what executives described as a “breakout year” in 2025, driven by expanding capabilities across its oncology, screening, and biopharma/data businesses and ...

In an advance for precision oncology, the largest published study to date on molecular residual disease (MRD) detection in stage 3 colon cancer has demonstrated the prognostic capabilities of Guardant ...

Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon ...

Guardant Health is scheduled to report fourth-quarter results Thursday after the market close, with investors focused on whether rapid growth in the company’s Shield colorectal cancer screening test ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it entered into privately negotiated exchange ...

Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced its intention to offer $300.0 million aggregate principal amount of convertible senior ...

PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (GH), a leading precision oncology company, today announced the pricing of its upsized offering of $350.0 million aggregate principal amount ...

New Guardant Reveal offering provides oncologists with tissue-free solution to monitor treatment response and detect early disease progression with unprecedented speed and sensitivity Reveal is ...